KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Short-Term Debt repayments (2019 - 2026)

Boston Scientific's Short-Term Debt repayments history spans 6 years, with the latest figure at $259.0 million for Q1 2026.

  • On a quarterly basis, Short-Term Debt repayments fell 76.08% to $259.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $771.0 million, a 28.81% decrease, with the full-year FY2025 number at $1.6 billion, up 216.47% from a year prior.
  • Short-Term Debt repayments hit $259.0 million in Q1 2026 for Boston Scientific, up from $12.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt repayments for BSX hit a ceiling of $1.1 billion in Q1 2025 and a floor of $12.0 million in Q3 2025.
  • Historically, Short-Term Debt repayments has averaged $434.7 million across 4 years, with a median of $379.5 million in 2025.
  • Biggest five-year swings in Short-Term Debt repayments: soared 114.88% in 2025 and later plummeted 76.08% in 2026.
  • Tracing BSX's Short-Term Debt repayments over 4 years: stood at $250.0 million in 2022, then soared by 101.6% to $504.0 million in 2024, then plummeted by 97.62% to $12.0 million in 2025, then surged by 2058.33% to $259.0 million in 2026.
  • Business Quant data shows Short-Term Debt repayments for BSX at $259.0 million in Q1 2026, $12.0 million in Q3 2025, and $500.0 million in Q2 2025.